Schrodinger (NASDAQ:SDGR - Free Report) had its target price decreased by KeyCorp from $32.00 to $30.00 in a research note published on Monday,Benzinga reports. KeyCorp currently has an overweight rating on the stock.
Separately, Morgan Stanley started coverage on Schrodinger in a research note on Thursday, July 3rd. They issued an "equal weight" rating and a $28.00 target price on the stock.
View Our Latest Analysis on SDGR
Schrodinger Stock Up 2.5%
Shares of NASDAQ:SDGR traded up $0.53 on Monday, reaching $21.78. 639,999 shares of the company's stock were exchanged, compared to its average volume of 921,833. The business's 50-day moving average is $22.03 and its two-hundred day moving average is $22.38. Schrodinger has a fifty-two week low of $16.60 and a fifty-two week high of $28.47. The firm has a market capitalization of $1.60 billion, a price-to-earnings ratio of -8.28 and a beta of 1.58.
Schrodinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.82) earnings per share for the quarter, missing the consensus estimate of ($0.81) by ($0.01). Schrodinger had a negative return on equity of 44.74% and a negative net margin of 83.39%. The business had revenue of $59.55 million for the quarter, compared to analyst estimates of $54.60 million. During the same quarter last year, the company earned ($0.86) EPS. Schrodinger's revenue was up 62.7% compared to the same quarter last year. Analysts predict that Schrodinger will post -2.37 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Schrodinger
A number of hedge funds have recently made changes to their positions in the business. Charles Schwab Investment Management Inc. boosted its position in Schrodinger by 2.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 509,680 shares of the company's stock worth $9,832,000 after acquiring an additional 11,167 shares during the period. Proficio Capital Partners LLC acquired a new position in Schrodinger during the 4th quarter valued at about $218,000. Raymond James Financial Inc. acquired a new position in Schrodinger during the 4th quarter valued at about $325,000. Amundi lifted its stake in shares of Schrodinger by 197.7% in the 4th quarter. Amundi now owns 26,753 shares of the company's stock worth $544,000 after acquiring an additional 17,766 shares during the period. Finally, Swiss National Bank boosted its holdings in shares of Schrodinger by 1.2% in the fourth quarter. Swiss National Bank now owns 125,100 shares of the company's stock valued at $2,413,000 after acquiring an additional 1,500 shares in the last quarter. Institutional investors own 79.05% of the company's stock.
About Schrodinger
(
Get Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Featured Articles
Before you consider Schrodinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrodinger wasn't on the list.
While Schrodinger currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
